Etanercept decreases synovial expression of tumour necrosis factor-α and lymphotoxin-α in rheumatoid arthritis. [electronic resource]
Producer: 20140527Description: 85-90 p. digitalISSN:- 1502-7732
- Adult
- Aged
- Antibodies, Monoclonal -- pharmacology
- Antirheumatic Agents -- pharmacology
- Arthritis, Rheumatoid -- drug therapy
- Arthroscopy
- Biopsy
- Etanercept
- Female
- Humans
- Image Processing, Computer-Assisted
- Immunoglobulin G -- pharmacology
- Immunohistochemistry
- Infliximab
- Lymphotoxin-alpha -- metabolism
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Synovial Membrane -- drug effects
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.